Compounds > nandrolone acetate
Page last updated: 2024-12-07

nandrolone acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nandrolone acetate is an anabolic steroid that is a synthetic derivative of testosterone. It is commonly used in the treatment of conditions such as anemia, osteoporosis, and breast cancer. Nandrolone acetate is synthesized from testosterone through a series of chemical reactions. It is a long-acting steroid with a half-life of approximately 12 days. The primary effect of nandrolone acetate is to increase protein synthesis and muscle growth. It also has anti-catabolic effects, which help to prevent muscle breakdown. Nandrolone acetate has been studied extensively for its potential therapeutic uses. It has been shown to be effective in the treatment of a number of conditions, including anemia, osteoporosis, and breast cancer. However, nandrolone acetate is also a controlled substance, and its use is subject to regulation. It is important to note that nandrolone acetate can have a number of side effects, including liver damage, cardiovascular problems, and mood swings. It is essential to consult with a healthcare professional before using nandrolone acetate.'

nandrolone acetate: causes chemical modification of delta(5)-3-ketoisomerase during its 3-oxo-4-estren-17 beta-yl acetate-dependent photoinactivation; RN given refers to (17beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102122
SCHEMBL ID2930366
MeSH IDM0064646

Synonyms (24)

Synonym
nsc73213
1425-10-1
17.beta.-acetoxy-19-nortestosterone
nsc-73213
nandrolone acetate
[(8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate
8z4nn9xf7d ,
(17beta)-17-(acetyloxy)estr-4-en-3-one
einecs 215-842-6
17beta-hydroxyestr-4-en-3-one 17-acetate
unii-8z4nn9xf7d
estr-4-en-3-one, 17-(acetyloxy)-, (17beta)-
17beta-acetoxy-19-nortestosterone
nsc 73213
AKOS022180454
SCHEMBL2930366
estr-4-en-3-one, 17-(acetyloxy)-, (17.beta.)-
17.beta.-(acetyloxy)estr-4-en-3-one
(17beta)-3-oxoestr-4-en-17-yl acetate
4-estren-17beta-ol-3-one acetate
19-nortestosterone acetate
DTXSID90931490
((8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta(a)phenanthren-17-yl)acetate
17.beta.-acetoxyestr-4-en-3-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (88.89)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.48 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
alanine
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.. alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.		1.9510alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
aspartic acid
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.. aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent. L-aspartic acid : The L-enantiomer of aspartic acid.		1.9510aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
norethindrone
Norethindrone: A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION.. norethisterone : A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen.		2.342017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol		progestin;
synthetic oral contraceptive
nandrolone
Nandrolone: C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.. nandrolone : A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17.		3.559017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid		human metabolite
phenyl acetate
phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid.		3.3270benzenes;
phenyl acetates
ConditionIndicatedRelationship StrengthStudiesTrials
Heavy Menstrual Bleeding
[description not available]		02.3420
Bleeding Between Periods
[description not available]		02.3420
Menorrhagia
Excessive uterine bleeding during MENSTRUATION.		02.3420
Metrorrhagia
Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.		02.3420
Bleeding
[description not available]		01.9310
Hemorrhage
Bleeding or escape of blood from a vessel.		01.9310
Endometrioma
An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.		01.9310
Endometriosis
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.		01.9310
Reproductive Sterility
[description not available]		01.9410
Sterility, Female
[description not available]		01.9410
Infertility
A reduced or absent capacity to reproduce.		01.9410
Infertility, Female
Diminished or absent ability of a female to achieve conception.		01.9410
Postpartum Amenorrhea
[description not available]		01.9310
Amenorrhea
Absence of menstruation.		01.9310
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.0110
Ischemia
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.		02.0110